Mucopolysaccharidosis Type IV

  • Vimizim 2021 report

    Vimizim 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Vonvendi 2020 report

    Vonvendi 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Vimizim 2019 report

    Vimizim 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Vimizim 2018 report

    Vimizim 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Vimizim 2017 report

    Vimizim 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Vimizim 2016 report

    Vimizim 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Vimizim 2015 report

    Vimizim 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Vimizim 2014 report

    Vimizim 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this Report:...